GLS-5310

N/A

Report date: 2023/01/31 14:34:03

Base Information

Drug NameGLS-5310

Drug Alias NameGLS-5310

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine

Mechanisms of ActionImmunostimulants

TargetsCoronavirus spike glycoprotein

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesPuerto RicoSouth Korea +[4]

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesGeneone Life Science Inc

China Registration ClassN/A

Develop Information

Active CompaniesGeneone Life Science Inc

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A